We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.32 | 0.65% | 49.33 | 49.00 | 49.44 | 49.45 | 48.98 | 49.25 | 1,187,885 | 00:59:59 |
From May 2019 to May 2024
PARIS--The World Health Organization granted prequalification status to the new pentavalent pediatric vaccine developed by French pharmaceutical company Sanofi SA (SAN.FR), a status that allows the vaccine to be purchased by United Nations agencies such as UNICEF.
The new vaccine, dubbed Shan5 and produced by Sanofi's Shantha unit in Hyderabad, India, is a fully-liquid five-in-one vaccine that protects children against five diseases: diphtheria, tetanus, pertussis, Hib (haemophilus influenzae type B) and hepatitis B.
-Write to Inti Landauro at inti.landauro@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
